AMRO B: Cost effectiveness results for Maternal and Neonatal Health
This Table provides summary results of the total population-level costs, effects and cost-effectiveness for the selected WHO sub-region and risk factor / disease for the year 2000.
KEY
I$ - International Dollars
Program Costs include costs of administration, media, training etc
Patient Costs include costs of hospital visits, drugs, etc
-
Summary
Summary of the methodologies used in the analysis -
Published research report
pdf, 167kb -
Excel Spreadsheet
xls, 93kb
Download this table in excel
| Interventions:Codes_and_Descriptions | Coverage | Cost per year (I$, millions) per one million_population [i.e. cost per capita] | % Program costs | % Patient costs | DALYs averted per year per one million_population | Average Cost per DALY averted | Incremental Cost per DALY averted |
| MNH-1: Community newborn care package | 50% | 0.08 | 23% | 77% | 894 | 87 | Dominated |
| MNH-2: Support for breastfeeding mothers | 50% | 0.08 | 21% | 79% | 717 | 115 | Dominated |
| MNH-3: Pre-eclampsia screening | 50% | 0.04 | 22% | 78% | 203 | 185 | Dominated |
| MNH-4: Tetanus toxoid | 50% | 0.05 | 18% | 82% | 2,247 | 20 | Dominated |
| MNH-5: Screening & treatment of asymptomatic bacteriuria | 50% | 0.03 | 31% | 69% | 77 | 345 | Dominated |
| MNH-6: Screening & treatment of syphilis | 50% | 0.03 | 28% | 72% | 31 | 941 | Dominated |
| MNH-7: Normal delivery by a skilled attendant | 50% | 0.11 | 11% | 89% | 1,540 | 72 | Dominated |
| MNH-8: Community-based case management for neonatal pneumonia | 50% | 0.00 | 52% | 48% | 98 | 17 | Dominated |
| MNH-9: Normal delivery by a skilled attendant + Tetanus Toxoid | 50% | 0.15 | 9% | 91% | 2,585 | 58 | Dominated |
| MNH-10: Management of maternal sepsis | 50% | 0.12 | 3% | 97% | 133 | 928 | Dominated |
| MNH-11: Management of severe neonatal asphyxia | 50% | 0.03 | 34% | 66% | 12 | 2,892 | Dominated |
| MNH-12: Management of serious newborn infections | 50% | 0.13 | 9% | 91% | 122 | 1,083 | Dominated |
| MNH-13: Management of very low birth weight babies | 50% | 0.05 | 24% | 76% | 111 | 447 | Dominated |
| MNH-14: Manangement of neonatal jaundice | 50% | 0.03 | 37% | 63% | 2 | 18,560 | Dominated |
| MNH-15: Tetanus toxoid + Pre-eclampsia screening | 50% | 0.07 | 14% | 86% | 2,450 | 27 | Dominated |
| MNH-16: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 50% | 0.07 | 20% | 80% | 2,528 | 27 | Dominated |
| MNH-17: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 50% | 0.07 | 23% | 77% | 2,557 | 29 | Dominated |
| MNH-18: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 50% | 0.17 | 11% | 89% | 3,261 | 51 | Dominated |
| MNH-19: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 50% | 0.15 | 12% | 88% | 2,736 | 57 | Dominated |
| MNH-20: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 50% | 0.33 | 5% | 95% | 2,673 | 123 | Dominated |
| MNH-21: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 50% | 0.21 | 9% | 91% | 3,325 | 64 | Dominated |
| MNH-22: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 50% | 0.21 | 12% | 88% | 2,607 | 81 | Dominated |
| MNH-23: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 50% | 0.30 | 6% | 94% | 2,753 | 111 | Dominated |
| MNH-24: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 50% | 0.20 | 6% | 94% | 2,821 | 72 | Dominated |
| MNH-25: Management of vLBW + Management of serious newborn infections | 50% | 0.25 | 7% | 93% | 233 | 1,059 | Dominated |
| MNH-26: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 50% | 0.27 | 6% | 94% | 245 | 1,099 | Dominated |
| MNH-27: ENC | 50% | 0.29 | 6% | 94% | 378 | 773 | Dominated |
| MNH-28: ENC + Management of maternal sepsis | 50% | 0.44 | 5% | 95% | 379 | 1,166 | Dominated |
| MNH-29: Community newborn care package + Community-based pneumonia | 50% | 0.10 | 38% | 62% | 992 | 100 | Dominated |
| MNH-30: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 50% | 0.18 | 15% | 85% | 2,882 | 64 | Dominated |
| MNH-31: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 50% | 0.23 | 12% | 88% | 3,029 | 75 | Dominated |
| MNH-32: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 50% | 0.28 | 10% | 90% | 2,957 | 93 | Dominated |
| MNH-33: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 50% | 0.31 | 10% | 90% | 2,983 | 103 | Dominated |
| MNH-34: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 50% | 0.33 | 8% | 92% | 2,974 | 112 | Dominated |
| MNH-35: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 50% | 0.37 | 8% | 92% | 2,998 | 123 | Dominated |
| MNH-36: Community newborn care package + Tetanus Toxoid | 50% | 0.12 | 21% | 79% | 3,141 | 39 | Dominated |
| MNH-37: Community-based pneumonia + Tetanus Toxoid | 50% | 0.05 | 19% | 81% | 2,345 | 20 | 20 |
| MNH-38: Community-based pneumonia + ANC | 50% | 0.08 | 23% | 77% | 2,655 | 28 | Dominated |
| MNH-39: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 50% | 0.14 | 32% | 68% | 3,239 | 45 | Dominated |
| MNH-40: Support for breastfeeding mothers + Tetanus toxoid | 50% | 0.13 | 20% | 80% | 2,964 | 43 | Dominated |
| MNH-41: Community newborn care package + ANC | 50% | 0.15 | 23% | 77% | 3,452 | 44 | Dominated |
| MNH-42: Community newborn care package + ANC + Community-based pneumonia | 50% | 0.17 | 32% | 68% | 3,550 | 49 | Dominated |
| MNH-43: Community newborn care package + ANC + Community-based pneumonia + SMNC | 50% | 0.31 | 25% | 75% | 4,700 | 65 | Dominated |
| MNH-44: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 50% | 0.22 | 30% | 70% | 3,661 | 61 | Dominated |
| MNH-45: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 50% | 0.55 | 17% | 83% | 5,010 | 109 | Dominated |
| MNH-46: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 50% | 0.36 | 25% | 75% | 4,811 | 74 | Dominated |
| MNH-47: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 50% | 0.35 | 22% | 78% | 4,848 | 72 | Dominated |
| MNH-48: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 50% | 0.50 | 17% | 83% | 5,015 | 101 | Dominated |
| MNH-49: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.53 | 16% | 84% | 4,935 | 107 | Dominated |
| MNH-50: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 50% | 0.66 | 12% | 88% | 5,075 | 131 | Dominated |
| MNH-51: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 50% | 0.40 | 22% | 78% | 4,959 | 80 | Dominated |
| MNH-52: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 50% | 0.17 | 31% | 69% | 3,521 | 48 | Dominated |
| MNH-53: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 50% | 0.64 | 15% | 85% | 5,225 | 123 | Dominated |
| MNH-54: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.53 | 16% | 84% | 4,935 | 107 | Dominated |
| MNH-55: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 50% | 0.15 | 21% | 79% | 3,422 | 43 | Dominated |
| MNH-56: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.77 | 12% | 88% | 5,379 | 143 | Dominated |
| MNH-57: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 50% | 0.66 | 13% | 87% | 5,103 | 129 | Dominated |
| MNH-58: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 50% | 0.55 | 14% | 86% | 5,000 | 109 | Dominated |
| MNH-59: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 50% | 0.59 | 13% | 87% | 5,010 | 119 | Dominated |
| MNH-60: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 50% | 0.56 | 16% | 84% | 4,958 | 114 | Dominated |
| MNH-61: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 50% | 0.79 | 12% | 88% | 5,313 | 150 | Dominated |
| MNH-62: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 50% | 0.95 | 11% | 89% | 5,481 | 173 | Dominated |
| MNH-63: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.25 | 15% | 85% | 4,155 | 59 | Dominated |
| MNH-64: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.76 | 11% | 89% | 5,350 | 143 | Dominated |
| MNH-65: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 50% | 0.95 | 11% | 89% | 5,481 | 173 | Dominated |
| MNH-66: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 50% | 0.89 | 11% | 89% | 5,388 | 164 | Dominated |
| MNH-67: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 50% | 0.84 | 12% | 88% | 5,378 | 156 | Dominated |
| MNH-68: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 50% | 1.04 | 10% | 90% | 5,556 | 187 | Dominated |
| MNH-69: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 50% | 0.99 | 10% | 90% | 5,545 | 179 | Dominated |
| MNH-70: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 50% | 1.01 | 11% | 89% | 5,503 | 184 | Dominated |
| MNH-71: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 50% | 1.10 | 9% | 91% | 5,573 | 197 | Dominated |
| MNH-72: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 50% | 1.08 | 9% | 91% | 5,620 | 193 | Dominated |
| MNH-73: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 50% | 1.14 | 9% | 91% | 5,638 | 202 | Dominated |
| MNH-74: Community newborn care package + Tetanus Toxoid + SMNC | 50% | 0.25 | 17% | 83% | 4,306 | 58 | Dominated |
| MNH-75: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.27 | 21% | 79% | 4,253 | 63 | Dominated |
| MNH-76: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 50% | 0.27 | 23% | 77% | 4,404 | 62 | Dominated |
| MNH-77: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.27 | 16% | 84% | 4,436 | 61 | Dominated |
| MNH-78: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.29 | 21% | 79% | 4,534 | 64 | Dominated |
| MNH-79: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 50% | 0.42 | 10% | 90% | 4,524 | 94 | Dominated |
| MNH-80: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.44 | 14% | 86% | 4,622 | 96 | Dominated |
| MNH-81: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 50% | 0.43 | 11% | 89% | 4,675 | 92 | Dominated |
| MNH-82: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.44 | 14% | 86% | 4,622 | 96 | Dominated |
| MNH-83: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 50% | 0.45 | 15% | 85% | 4,773 | 94 | Dominated |
| MNH-84: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 50% | 0.34 | 20% | 80% | 4,833 | 70 | Dominated |
| MNH-85: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 50% | 0.52 | 14% | 86% | 4,920 | 105 | Dominated |
| MNH-86: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 50% | 0.43 | 16% | 84% | 4,908 | 87 | Dominated |
| MNH-87: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 50% | 0.38 | 18% | 82% | 4,897 | 78 | Dominated |
| MNH-88: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 50% | 0.47 | 14% | 86% | 4,972 | 95 | Dominated |
| MNH-89: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.92 | 9% | 91% | 5,437 | 169 | Dominated |
| MNH-90: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.92 | 10% | 90% | 5,467 | 169 | Dominated |
| MNH-91: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 50% | 0.98 | 9% | 91% | 5,484 | 179 | Dominated |
| MNH-92: Community newborn care package | 80% | 0.14 | 29% | 71% | 1,431 | 95 | Dominated |
| MNH-93: Support for breastfeeding mothers | 80% | 0.14 | 27% | 73% | 1,147 | 124 | Dominated |
| MNH-94: Pre-eclampsia screening | 80% | 0.07 | 25% | 75% | 325 | 206 | Dominated |
| MNH-95: Tetanus toxoid | 80% | 0.08 | 21% | 79% | 3,595 | 22 | Dominated |
| MNH-96: Screening & treatment of asymptomatic bacteriuria | 80% | 0.05 | 34% | 66% | 124 | 390 | Dominated |
| MNH-97: Screening & treatment of syphilis | 80% | 0.05 | 32% | 68% | 49 | 1,055 | Dominated |
| MNH-98: Normal delivery by a skilled attendant | 80% | 0.18 | 13% | 87% | 2,465 | 74 | Dominated |
| MNH-99: Community-based case management for neonatal pneumonia | 80% | 0.00 | 48% | 52% | 157 | 15 | 15 |
| MNH-100: Normal delivery by a skilled attendant + Tetanus Toxoid | 80% | 0.25 | 10% | 90% | 4,136 | 60 | Dominated |
| MNH-101: Management of maternal sepsis | 80% | 0.21 | 2% | 98% | 212 | 971 | Dominated |
| MNH-102: Management of severe neonatal asphyxia | 80% | 0.06 | 38% | 62% | 19 | 3,217 | Dominated |
| MNH-103: Management of serious newborn infections | 80% | 0.23 | 10% | 90% | 196 | 1,152 | Dominated |
| MNH-104: Management of very low birth weight babies | 80% | 0.09 | 27% | 73% | 177 | 489 | Dominated |
| MNH-105: Manangement of neonatal jaundice | 80% | 0.06 | 41% | 59% | 3 | 20,848 | Dominated |
| MNH-106: Tetanus toxoid + Pre-eclampsia screening | 80% | 0.11 | 16% | 84% | 3,920 | 29 | Dominated |
| MNH-107: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 80% | 0.12 | 21% | 79% | 4,045 | 30 | Dominated |
| MNH-108: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 80% | 0.13 | 24% | 76% | 4,092 | 31 | Dominated |
| MNH-109: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 80% | 0.27 | 13% | 87% | 5,217 | 52 | Dominated |
| MNH-110: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 80% | 0.26 | 13% | 87% | 4,378 | 59 | Dominated |
| MNH-111: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 80% | 0.56 | 6% | 94% | 4,276 | 131 | Dominated |
| MNH-112: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 80% | 0.33 | 11% | 89% | 5,320 | 61 | Dominated |
| MNH-113: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 80% | 0.34 | 9% | 91% | 4,172 | 81 | Dominated |
| MNH-114: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 80% | 0.52 | 7% | 93% | 4,404 | 117 | Dominated |
| MNH-115: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 80% | 0.34 | 7% | 93% | 4,514 | 76 | Dominated |
| MNH-116: Management of vLBW + Management of serious newborn infections | 80% | 0.42 | 7% | 93% | 373 | 1,118 | Dominated |
| MNH-117: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 80% | 0.45 | 7% | 93% | 392 | 1,160 | Dominated |
| MNH-118: Emergency neonatal care | 80% | 0.49 | 7% | 93% | 604 | 815 | Dominated |
| MNH-119: ENC + Management of maternal sepsis | 80% | 0.74 | 5% | 95% | 607 | 1,223 | Dominated |
| MNH-120: Community newborn care package + Community-based pneumonia | 80% | 0.14 | 28% | 72% | 1,588 | 86 | Dominated |
| MNH-121: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 80% | 0.31 | 16% | 84% | 4,611 | 66 | Dominated |
| MNH-122: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 80% | 0.36 | 14% | 86% | 4,846 | 75 | Dominated |
| MNH-123: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 80% | 0.43 | 12% | 88% | 4,731 | 91 | Dominated |
| MNH-124: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 80% | 0.51 | 11% | 89% | 4,773 | 108 | Dominated |
| MNH-125: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 80% | 0.52 | 10% | 90% | 4,759 | 109 | Dominated |
| MNH-126: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 80% | 0.61 | 9% | 91% | 4,797 | 128 | Dominated |
| MNH-127: Community newborn care package + Tetanus Toxoid | 80% | 0.22 | 26% | 74% | 5,026 | 43 | Dominated |
| MNH-128: Community-based pneumonia + Tetanus Toxoid | 80% | 0.08 | 22% | 78% | 3,752 | 22 | 25 |
| MNH-129: Community-based pneumonia + ANC | 80% | 0.13 | 25% | 75% | 4,248 | 31 | Dominated |
| MNH-130: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 80% | 0.22 | 25% | 75% | 5,183 | 42 | Dominated |
| MNH-131: Support for breastfeeding mothers + Tetanus toxoid | 80% | 0.22 | 25% | 75% | 4,742 | 47 | Dominated |
| MNH-132: Community newborn care package + ANC | 80% | 0.26 | 26% | 74% | 5,523 | 48 | Dominated |
| MNH-133: Community newborn care package + ANC + Community-based pneumonia | 80% | 0.26 | 26% | 74% | 5,680 | 47 | Dominated |
| MNH-134: Community newborn care package + ANC + Community-based pneumonia + SMNC | 80% | 0.48 | 23% | 77% | 7,521 | 63 | Dominated |
| MNH-135: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 80% | 0.35 | 26% | 74% | 5,857 | 60 | Dominated |
| MNH-136: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 80% | 0.80 | 14% | 86% | 8,015 | 100 | Dominated |
| MNH-137: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 80% | 0.56 | 23% | 77% | 7,698 | 73 | Dominated |
| MNH-138: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 80% | 0.53 | 20% | 80% | 7,757 | 69 | Dominated |
| MNH-139: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 80% | 0.80 | 15% | 85% | 8,024 | 100 | Dominated |
| MNH-140: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.85 | 14% | 86% | 7,897 | 107 | Dominated |
| MNH-141: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 80% | 1.03 | 11% | 89% | 8,120 | 127 | Dominated |
| MNH-142: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 80% | 0.62 | 21% | 79% | 7,934 | 78 | Dominated |
| MNH-143: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 80% | 0.26 | 25% | 75% | 5,633 | 46 | Dominated |
| MNH-144: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 80% | 1.03 | 14% | 86% | 8,361 | 123 | Dominated |
| MNH-145: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.85 | 14% | 86% | 7,897 | 107 | Dominated |
| MNH-146: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 80% | 0.26 | 25% | 75% | 5,476 | 47 | Dominated |
| MNH-147: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.20 | 11% | 89% | 8,607 | 139 | Dominated |
| MNH-148: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 80% | 1.06 | 11% | 89% | 8,165 | 130 | Dominated |
| MNH-149: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 80% | 0.84 | 13% | 87% | 8,000 | 105 | Dominated |
| MNH-150: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 80% | 0.92 | 12% | 88% | 8,017 | 114 | Dominated |
| MNH-151: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 80% | 0.88 | 13% | 87% | 7,932 | 111 | Dominated |
| MNH-152: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 80% | 1.28 | 11% | 89% | 8,501 | 151 | Dominated |
| MNH-153: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 80% | 1.55 | 10% | 90% | 8,769 | 177 | Dominated |
| MNH-154: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.41 | 18% | 82% | 6,648 | 61 | Dominated |
| MNH-155: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.19 | 11% | 89% | 8,560 | 139 | Dominated |
| MNH-156: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 80% | 1.55 | 10% | 90% | 8,769 | 177 | Dominated |
| MNH-157: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 80% | 1.41 | 10% | 90% | 8,621 | 163 | Dominated |
| MNH-158: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 80% | 1.34 | 11% | 89% | 8,604 | 155 | Dominated |
| MNH-159: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 80% | 1.68 | 9% | 91% | 8,889 | 189 | Dominated |
| MNH-160: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 80% | 1.60 | 9% | 91% | 8,872 | 181 | Dominated |
| MNH-161: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.64 | 10% | 90% | 8,804 | 186 | Dominated |
| MNH-162: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.76 | 9% | 91% | 8,917 | 198 | Dominated |
| MNH-163: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 80% | 1.73 | 9% | 91% | 8,992 | 192 | Dominated |
| MNH-164: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 80% | 1.82 | 8% | 92% | 9,021 | 201 | Dominated |
| MNH-165: Community newborn care package + Tetanus Toxoid + SMNC | 80% | 0.42 | 20% | 80% | 6,889 | 60 | Dominated |
| MNH-166: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.41 | 18% | 82% | 6,805 | 60 | Dominated |
| MNH-167: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 80% | 0.42 | 20% | 80% | 7,046 | 59 | Dominated |
| MNH-168: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.45 | 19% | 81% | 7,098 | 63 | Dominated |
| MNH-169: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.45 | 18% | 82% | 7,255 | 62 | Dominated |
| MNH-170: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 80% | 0.70 | 12% | 88% | 7,238 | 97 | Dominated |
| MNH-171: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.70 | 12% | 88% | 7,395 | 95 | Dominated |
| MNH-172: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 80% | 0.71 | 13% | 87% | 7,479 | 95 | Dominated |
| MNH-173: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.70 | 12% | 88% | 7,395 | 95 | Dominated |
| MNH-174: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 80% | 0.71 | 13% | 87% | 7,636 | 93 | Dominated |
| MNH-175: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 80% | 0.52 | 18% | 82% | 7,732 | 67 | Dominated |
| MNH-176: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 80% | 0.83 | 12% | 88% | 7,872 | 105 | Dominated |
| MNH-177: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 80% | 0.64 | 14% | 86% | 7,852 | 82 | Dominated |
| MNH-178: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 80% | 0.57 | 16% | 84% | 7,835 | 73 | Dominated |
| MNH-179: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 80% | 0.70 | 13% | 87% | 7,955 | 87 | Dominated |
| MNH-180: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.44 | 9% | 91% | 8,700 | 166 | Dominated |
| MNH-181: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.45 | 9% | 91% | 8,747 | 166 | Dominated |
| MNH-182: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 80% | 1.54 | 9% | 91% | 8,775 | 175 | Dominated |
| MNH-183: Community newborn care package | 95% | 0.17 | 33% | 67% | 1,699 | 101 | Dominated |
| MNH-184: Support for breastfeeding mothers | 95% | 0.18 | 31% | 69% | 1,362 | 132 | Dominated |
| MNH-185: Pre-eclampsia screening | 95% | 0.10 | 30% | 70% | 385 | 272 | Dominated |
| MNH-186: Tetanus toxoid | 95% | 0.12 | 26% | 74% | 4,269 | 28 | Dominated |
| MNH-187: Screening & treatment of asymptomatic bacteriuria | 95% | 0.08 | 41% | 59% | 147 | 512 | Dominated |
| MNH-188: Screening & treatment of syphilis | 95% | 0.08 | 39% | 61% | 59 | 1,359 | Dominated |
| MNH-190: Normal delivery by a skilled attendant | 95% | 0.23 | 19% | 81% | 2,927 | 79 | Dominated |
| MNH-191: Community-based case management for neonatal pneumonia | 95% | 0.00 | 49% | 51% | 186 | 16 | 17 |
| MNH-193: Normal delivery by a skilled attendant + Tetanus Toxoid | 95% | 0.32 | 14% | 86% | 4,912 | 66 | Dominated |
| MNH-194: Management of maternal sepsis | 95% | 0.27 | 2% | 98% | 252 | 1,079 | Dominated |
| MNH-195: Management of severe neonatal asphyxia | 95% | 0.09 | 46% | 54% | 23 | 4,130 | Dominated |
| MNH-196: Management of serious newborn infections | 95% | 0.31 | 14% | 86% | 232 | 1,335 | Dominated |
| MNH-197: Management of very low birth weight babies | 95% | 0.13 | 34% | 66% | 210 | 604 | Dominated |
| MNH-198: Manangement of neonatal jaundice | 95% | 0.09 | 49% | 51% | 3 | 27,269 | Dominated |
| MNH-199: Tetanus toxoid + Pre-eclampsia screening | 95% | 0.17 | 20% | 80% | 4,656 | 36 | Dominated |
| MNH-200: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 95% | 0.18 | 24% | 76% | 4,803 | 37 | Dominated |
| MNH-201: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 95% | 0.19 | 27% | 73% | 4,859 | 38 | Dominated |
| MNH-202: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 95% | 0.35 | 17% | 83% | 6,195 | 57 | Dominated |
| MNH-203: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 95% | 0.34 | 17% | 83% | 5,198 | 65 | Dominated |
| MNH-204: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 95% | 0.78 | 7% | 93% | 5,078 | 154 | Dominated |
| MNH-205: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 95% | 0.41 | 15% | 85% | 6,318 | 65 | Dominated |
| MNH-206: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 95% | 0.45 | 12% | 88% | 4,954 | 92 | Dominated |
| MNH-207: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 95% | 0.70 | 8% | 92% | 5,230 | 135 | Dominated |
| MNH-208: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 95% | 0.45 | 10% | 90% | 5,361 | 85 | Dominated |
| MNH-209: Management of vLBW + Management of serious newborn infections | 95% | 0.56 | 9% | 91% | 443 | 1,270 | Dominated |
| MNH-210: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 95% | 0.61 | 8% | 92% | 465 | 1,317 | Dominated |
| MNH-211: Emergency neonatal care | 95% | 0.66 | 8% | 92% | 718 | 924 | Dominated |
| MNH-212: ENC + Management of maternal sepsis | 95% | 0.99 | 6% | 94% | 721 | 1,370 | Dominated |
| MNH-213: Community newborn care package + Community-based pneumonia | 95% | 0.15 | 25% | 75% | 1,886 | 82 | Dominated |
| MNH-214: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 95% | 0.40 | 19% | 81% | 5,475 | 74 | Dominated |
| MNH-215: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 95% | 0.47 | 17% | 83% | 5,755 | 82 | Dominated |
| MNH-216: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 95% | 0.55 | 14% | 86% | 5,618 | 99 | Dominated |
| MNH-217: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 95% | 0.68 | 13% | 87% | 5,667 | 120 | Dominated |
| MNH-218: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 95% | 0.66 | 12% | 88% | 5,651 | 117 | Dominated |
| MNH-219: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 95% | 0.82 | 11% | 89% | 5,696 | 143 | Dominated |
| MNH-221: Community newborn care package + Tetanus Toxoid | 95% | 0.29 | 30% | 70% | 5,969 | 49 | Dominated |
| MNH-222: Community-based pneumonia + Tetanus Toxoid | 95% | 0.12 | 26% | 74% | 4,455 | 28 | 57 |
| MNH-223: Community-based pneumonia + ANC | 95% | 0.19 | 27% | 73% | 5,045 | 37 | Dominated |
| MNH-224: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 95% | 0.27 | 25% | 75% | 6,155 | 45 | 89 |
| MNH-225: Support for breastfeeding mothers + Tetanus toxoid | 95% | 0.30 | 29% | 71% | 5,631 | 53 | Dominated |
| MNH-227: Community newborn care package + ANC | 95% | 0.36 | 30% | 70% | 6,558 | 54 | Dominated |
| MNH-228: Community newborn care package + ANC + Community-based pneumonia | 95% | 0.34 | 26% | 74% | 6,745 | 51 | Dominated |
| MNH-229: Community newborn care package + ANC + Community-based pneumonia + SMNC | 95% | 0.60 | 24% | 76% | 8,931 | 67 | Dominated |
| MNH-230: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 95% | 0.47 | 28% | 72% | 6,955 | 67 | Dominated |
| MNH-232: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 95% | 1.01 | 15% | 85% | 9,518 | 106 | Dominated |
| MNH-233: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 95% | 0.73 | 26% | 74% | 9,141 | 79 | Dominated |
| MNH-235: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 95% | 0.67 | 22% | 78% | 9,211 | 73 | Dominated |
| MNH-236: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 95% | 1.05 | 15% | 85% | 9,529 | 110 | Dominated |
| MNH-237: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 1.13 | 14% | 86% | 9,377 | 120 | Dominated |
| MNH-240: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 95% | 1.33 | 11% | 89% | 9,643 | 138 | Dominated |
| MNH-241: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 95% | 0.80 | 23% | 77% | 9,421 | 85 | Dominated |
| MNH-242: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 95% | 0.33 | 24% | 76% | 6,689 | 49 | 104 |
| MNH-243: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 95% | 1.33 | 15% | 85% | 9,928 | 134 | Dominated |
| MNH-244: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 1.13 | 14% | 86% | 9,377 | 120 | Dominated |
| MNH-245: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 95% | 0.35 | 28% | 72% | 6,503 | 53 | Dominated |
| MNH-246: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.53 | 12% | 88% | 10,220 | 149 | 900 |
| MNH-247: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 95% | 1.38 | 11% | 89% | 9,695 | 142 | Dominated |
| MNH-248: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 95% | 1.06 | 14% | 86% | 9,500 | 111 | Dominated |
| MNH-249: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 95% | 1.15 | 13% | 87% | 9,520 | 121 | Dominated |
| MNH-250: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 95% | 1.13 | 14% | 86% | 9,419 | 120 | Dominated |
| MNH-251: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 95% | 1.66 | 12% | 88% | 10,095 | 165 | Dominated |
| MNH-252: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 95% | 2.04 | 10% | 90% | 10,413 | 196 | Dominated |
| MNH-253: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.52 | 23% | 77% | 7,895 | 66 | Dominated |
| MNH-254: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.52 | 12% | 88% | 10,165 | 149 | Dominated |
| MNH-255: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 95% | 2.04 | 10% | 90% | 10,413 | 196 | Dominated |
| MNH-256: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 95% | 1.81 | 11% | 89% | 10,237 | 177 | Dominated |
| MNH-257: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 95% | 1.72 | 12% | 88% | 10,217 | 168 | Dominated |
| MNH-258: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 95% | 2.19 | 10% | 90% | 10,556 | 208 | Dominated |
| MNH-259: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 95% | 2.10 | 10% | 90% | 10,536 | 199 | Dominated |
| MNH-260: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 95% | 2.17 | 10% | 90% | 10,455 | 208 | Dominated |
| MNH-261: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 95% | 2.30 | 9% | 91% | 10,589 | 217 | Dominated |
| MNH-262: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 95% | 2.25 | 9% | 91% | 10,678 | 211 | 1,579 |
| MNH-263: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 95% | 2.36 | 9% | 91% | 10,712 | 220 | 3,225 |
| MNH-264: Community newborn care package + Tetanus Toxoid + SMNC | 95% | 0.54 | 24% | 76% | 8,181 | 66 | Dominated |
| MNH-265: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.51 | 20% | 80% | 8,081 | 63 | Dominated |
| MNH-266: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 95% | 0.52 | 22% | 78% | 8,368 | 62 | Dominated |
| MNH-267: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.58 | 22% | 78% | 8,429 | 69 | Dominated |
| MNH-268: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.56 | 20% | 80% | 8,615 | 65 | 121 |
| MNH-269: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 95% | 0.91 | 14% | 86% | 8,595 | 106 | Dominated |
| MNH-270: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 0.89 | 12% | 88% | 8,782 | 102 | Dominated |
| MNH-271: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 95% | 0.92 | 15% | 85% | 8,882 | 104 | Dominated |
| MNH-272: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 0.89 | 12% | 88% | 8,782 | 102 | Dominated |
| MNH-273: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 95% | 0.90 | 14% | 86% | 9,068 | 100 | Dominated |
| MNH-274: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 95% | 0.65 | 19% | 81% | 9,182 | 70 | 145 |
| MNH-275: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 95% | 1.10 | 12% | 88% | 9,348 | 118 | Dominated |
| MNH-276: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 95% | 0.80 | 15% | 85% | 9,324 | 85 | Dominated |
| MNH-277: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 95% | 0.70 | 18% | 82% | 9,305 | 76 | 472 |
| MNH-278: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 95% | 0.85 | 14% | 86% | 9,447 | 90 | Dominated |
| MNH-279: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.85 | 10% | 90% | 10,331 | 179 | Dominated |
| MNH-280: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.86 | 10% | 90% | 10,387 | 179 | Dominated |
| MNH-281: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 95% | 1.97 | 10% | 90% | 10,420 | 189 | Dominated |
| MNH-282: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 1.11 | 18% | 82% | 9,459 | 117 | Dominated |
| MNH-283: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW | 95% | 0.65 | 24% | 76% | 8,578 | 75 | Dominated |
| MNH-284: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 1.03 | 16% | 84% | 8,896 | 115 | Dominated |
| MNH-285: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term + Treatment of severe PEE | 95% | 1.18 | 17% | 83% | 9,739 | 121 | Dominated |
| MNH-286: Community newborn care package + ANC + Community-based pneumonia + SMNC + ENC + Steroids pre-term + Treatment of severe PEE | 95% | 1.71 | 12% | 88% | 10,247 | 167 | Dominated |